Endothelial dysfunction after androgen deprivation therapy and the possible underlying mechanisms.
Jeremy Yuen-Chun Teoh, Xiao-Yu Tian, Christine Yim-Ping Wong...
https://pubmed.ncbi.nlm.nih.gov/34570375/Actively Recruiting
Age: 18Years - 80Years
MALE
ID06163924
Studying How Team-Based Care Can Improve Heart Health in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
Led by Chinese University of Hong Kong · Updated on 2025-05-06
130
Participants Needed
1
Research Sites
12 weeks
Total Duration
AI-Summary
What this Trial Is About
Prostate cancer is a common and often slow-progressing cancer in adult men, with many patients living several years even with metastatic disease. Androgen deprivation therapy ADT is widely used to control prostate cancer, but it may increase the risk of cardiovascular problems. Researchers are evaluating whether a multidisciplinary care approach with close cardiovascular monitoring can reduce these risks and improve health outcomes for prostate cancer patients receiving ADT. This observational study aims to fill gaps in knowledge about the best ways to monitor and manage cardiovascular risks in these patients.
CONDITIONS
Brief Title
The Effect of Multidisciplinary Care Approach on CV Risk Modification in CaP Patients Receiving ADT
Research Team
C
Chi Fai NG, Professor
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here